| 000 | 01789 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515183429.0 | ||
| 264 | 0 | _c20100310 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a1432-0584 | ||
| 024 | 7 |
_a10.1007/s00277-009-0808-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTsirigotis, Panagiotis | |
| 245 | 0 | 0 |
_aPost-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin's lymphoma. _h[electronic resource] |
| 260 |
_bAnnals of hematology _cMar 2010 |
||
| 300 |
_a263-72 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _xmortality |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aSecondary Prevention |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aDray, Liliane | |
| 700 | 1 | _aResnick, Igor B | |
| 700 | 1 | _aAckerstein, Aliza | |
| 700 | 1 | _aGesundheit, Benjamin | |
| 700 | 1 | _aElad, Sharon | |
| 700 | 1 | _aOr, Reuven | |
| 700 | 1 | _aShapira, Michael-Yechiel | |
| 773 | 0 |
_tAnnals of hematology _gvol. 89 _gno. 3 _gp. 263-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00277-009-0808-5 _zAvailable from publisher's website |
| 999 |
_c19096068 _d19096068 |
||